Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER

Cancer Letters

Volumn 99, Issue 2, 1996, Pages 209-215

  Long, Brian J ^a   Rose, David P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Breast cancer; Epidermal growth factor; Estrogen receptor; Plasminogen activator

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA; UROKINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; ENZYME RELEASE; EXPRESSION VECTOR; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0030069296     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04066-8     Document Type: Article

References (22)

1. Albini, A., Graf, J., Kitten, G.T., Kleinman, H.K., Martin, G.R., Veillette, A. and Lippman, M.E. (1986) 17β-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF-7 breast cancer cell interactions with basement membrane. Proc. Natl. Acad. Sci. USA, 83, 8182-8186.
2. Bouchet, C., Spyratos, F., Martin, P.M., Hacène, K., Gentile, A. and Oglobine, J. (1994) Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PA1-1 and PA1-2 in breast carcinomas. Br. J. Cancer, 69, 398-405.
3. Chomczynski, P. and Sacchi, N. (1987) Single step method of RNA isolation by acid guandinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
4. Dano, K., Andraeson, P.A., Grondahl-Hansen, J., Kristensen, P., Neilsen, L.S. and Skriver, L. (1985) Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res., 44, 139-226.
5. Davidson, N.E., Gelmann, E.P., Lippman, M.E. and Dickson, R.B. (1987) Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol. Endocrinol., 1, 216-223.
6. Ennis, B.W., Valverius, E.M., Bates, S.E., Lippman, M.E. et al. (1989) Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-MB-468 human breast cancer cells. Mol. Endocrinol., 3, 1830-1838.
7. Garcia, M., Derocq, D., Freiss, G. and Rochefort, H. (1992) Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc. Natl. Acad. Sci. USA, 89, 11538-11542.
8. Heussen, C. and Dowdle, E.B. (1980) Electrophoresis analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem.. 102, 196-202.
9. Hoosein, N.M., Boyd, D.D., Hollas, W.J., Mazar, A., Henkin, J. and Chung, L.W.K. (1991) Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Commun., 3, 255-264.
10. Jänicke, F., Schmitt, M., Pache, L., Ulm, K., Harbeck, N., Höfler, H. and Graeff, H. (1993) Urokinase (uPA) and its inhibitor PA1-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res. Treat., 24, 195-208.
11. Jeng, M.-H., Jiang, S.-Y. and Jordan, V.C. (1994) Paradoxical regulation of estrogen-dependent growth factor gene expression in estrogen receptor (ER)-negative human breast cancer cells stably expressing ER. Cancer Lett., 82, 123-128.
12. Jiang, S.-Y. and Jordan, V.C. (1992) Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst., 84, 580-591.
13. Lund-Johansen, M., Bjerkvig, R., Humphrey, P.A., Bigner, S.H., Bigner, D.D. and Laerum, O.-D. (1990) Effect of epidermal growth factor on glioma cell growth, migration and invasion in vitro. Cancer Res., 50, 6039-6044.
14. Perroteau, I., Salomon, D., DeBartoli, M., Kidwell, W., Hazarika, P., Pardue, R., Dedman, J. and Tam, J. (1986) Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells. Breast Cancer Res. Treat., 7, 201-210.
15. Pourreau-Schneider, N., Delori, P., Boutière, B., Arnoux, D., George, F., Sampol, J. and Martin, P.M. (1989) Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231. J. Natl. Cancer Inst., 81, 259-266.
16. Rose, D.P., Connolly, J.M. and Liu, X.-H. (1994) Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res., 54, 6557-6562.
17. Sundareshan, P., Misiorowski, R.L., Davis, J.R., Kore, M. and Hendrix, M.J.C. (1991) Effects of epidermal growth factor on growth response, morphology and invasive potential of human endometrial carcinoma cell line RL95-2. Cancer Commun., 3, 149-158.
18. Tranque, P., Naftolin, F. and Robbins, R. (1994) Differential regulation of astrocyte plasminogen activators by insulin-like growth factor-1 and epidermal growth factor. Endocrinology, 134, 2606-2613.
19. Yamashita, J., Inada, K., Yamashita, S., Matsuo, S., Nakashima, Y. and Ogawa, M. (1992) Demonstration of a possible link between high grade malignancy in dimethylbenz[a]anthracene-induced rat mammary carcinoma and increased urokinase plasminogen activator content. Int. J. Clin. Lab. Res., 22, 165-168.
20. Yudoh, K., Matsui, H., Kanamori, M., Maeda, A., Ohmori, K. and Tsuji, H. (1994) Effects of epidermal growth factor on invasiveness through the extracellular matrix in high- and low-metastatic clones of RCT sarcoma in vitro. Jpn. J. Cancer Res., 85, 63-71.
21. Duffy, M.J., O'Grady, P., Simon, J., Rose, M. and Lijnen, H.R. (1986) Tissue-type plasminogen activator in breast cancer: relationship with estradiol and progesterone receptors. J. Natl. Cancer Inst., 77, 621-623.
22. Ryan, T.J., Seeger, J.I., Kumar, S.A. and Dickerman, H.W. (1984) Estradiol preferentially enhances extracellular tissue plasminogen activators of MCF-7 breast cancer cells. J. Biol. Chem., 259, 14324-14327.